Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life.
Bagnasco D, Povero M, Pradelli L, Brussino L, Rolla G, Caminati M, Menzella F, Heffler E, Canonica GW, Paggiaro P, Senna G, Milanese M, Lombardi C, Bucca C, Manfredi A, Canevari RF, Passalacqua G; SANI Network (Severe Asthma Network Italy). Bagnasco D, et al. Among authors: menzella f. World Allergy Organ J. 2021 Jan 27;14(2):100509. doi: 10.1016/j.waojou.2021.100509. eCollection 2021 Feb. World Allergy Organ J. 2021. PMID: 33598095 Free PMC article.
A survey of clinical features of allergic rhinitis in adults.
Frati F, Dell'Albani I, Passalacqua G, Bonini S, Rossi O, Senna G, Incorvaia C; Adult SURF Study Group. Frati F, et al. Med Sci Monit. 2014 Nov 4;20:2151-6. doi: 10.12659/MSM.891206. Med Sci Monit. 2014. PMID: 25366169 Free PMC article.
Tailored therapy for severe asthma.
Menzella F, Lusuardi M, Galeone C, Zucchi L. Menzella F, et al. Multidiscip Respir Med. 2015 Jan 16;10(1):1. doi: 10.1186/2049-6958-10-1. eCollection 2015. Multidiscip Respir Med. 2015. PMID: 25671117 Free PMC article. Review.
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A, Luppi F, D'Amico R, Balduzzi S, Vicini R, Liverani A, Ruggieri V, Plebani M, Barbaro MP, Spanevello A, Canonica GW, Papi A, Fabbri LM, Beghè B; FARM58J2XH Study Group. Verduri A, et al. PLoS One. 2015 Mar 11;10(3):e0118241. doi: 10.1371/journal.pone.0118241. eCollection 2015. PLoS One. 2015. PMID: 25760346 Free PMC article. Clinical Trial.
Clinical usefulness of mepolizumab in severe eosinophilic asthma.
Menzella F, Lusuardi M, Montanari G, Galeone C, Facciolongo N, Zucchi L. Menzella F, et al. Ther Clin Risk Manag. 2016 Jun 8;12:907-16. doi: 10.2147/TCRM.S86299. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27354806 Free PMC article. Review.
Real-life Efficacy of Omalizumab After 9 Years of Follow-up.
Menzella F, Galeone C, Formisano D, Castagnetti C, Ruggiero P, Simonazzi A, Zucchi L. Menzella F, et al. Allergy Asthma Immunol Res. 2017 Jul;9(4):368-372. doi: 10.4168/aair.2017.9.4.368. Allergy Asthma Immunol Res. 2017. PMID: 28497924 Free PMC article.
110 results